Medical Research
(H123)
IRS Verified
DX Registered
NATIONAL LEIOMYOSARCOMA FOUNDATION
CharityAI™ Score
Not yet evaluated
Mission Statement
- Provide annual patient education symposium series programs throughout the United States, partnering with cancer treatment research centers and research oncology. - Promote patient advocacy on issues that affect research efforts, treatment advancements, clinical trials, and drug development. - Provide vigorous LMS research funding for promising LMS research projects that have the potential to accelerate treatment options for extending survival.
Financial Overview — FY 2023
$258K
Total Revenue
$259K
Total Expenses
N/A
Net Assets
0
Employees
Program Expense Ratio
N/A
Fundraising Efficiency
N/A
Operating Reserve
N/A
Liability-to-Asset
N/A
Revenue Diversification
N/A
Executive Compensation
$0
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $258K | $259K | N/A | — | 0 |
| 2022 | $265K | $135K | N/A | — | 0 |
| 2021 | $180K | $90K | N/A | — | 0 |
Donor Reviews
No reviews yet
Be the first to share your experience with this organization.